Safer antibiotic choices before knee, hip, or shoulder replacement for people labeled allergic to penicillin or other beta-lactams
Official title: Optimization of Perioperative Antibiotic Prophylaxis in Patients Allergic to Beta-lactams in the Orthopedic Surgery and Trauma Departments of the Strasbourg University Hospitals
Run by University Hospital, Strasbourg, France · NCT07342647 · Data updated 2026-11-12
This project will see if using the PEN-FAST allergy score at the pre-op anesthesiology visit helps doctors choose the safest antibiotic for adults labeled allergic to beta-lactams who are having knee, hip, or shoulder replacement.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | July 11, 2025 |
| Main results expected | July 2026 |
| Study ends | July 11, 2026 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT07342647 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) labeled as allergic to beta-lactams who undergo total knee, shoulder, or hip replacement at Strasbourg University Hospital during the specified enrollment windows and require intraoperative antibiotic prophylaxis.
✕Probably not a fit
Patients without a beta-lactam allergy label, those undergoing procedures that do not use implants or do not require antibiotic prophylaxis, and individuals with a confirmed severe beta-lactam hypersensitivity are unlikely to benefit from this work.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational program uses preoperative anesthesiology consultations and the PEN-FAST scoring system to stratify risk of true penicillin allergy among adults labeled as allergic to beta-lactams. It includes a retrospective cohort of surgeries performed in 2023 and a prospective cohort of qualifying surgeries performed in 2025 at Strasbourg University Hospital. The study documents which antibiotic prophylaxis agents were chosen and whether PEN-FAST risk strata influenced prescribing or delabeling decisions. Data will be used to characterize current practice and the feasibility of applying PEN-FAST to perioperative antibiotic selection in orthopedic implant surgery.
Why it matters
Potential benefit: If successful, more patients could safely receive first-line beta-lactam prophylaxis, reducing reliance on broader alternatives and potentially lowering infection rates and antimicrobial resistance.
How similar studies have gone: The PEN-FAST score has been externally validated and used in delabeling pathways with good negative predictive value, but applying it specifically to perioperative antibiotic selection for orthopedic implants remains less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient (≥ 18 years old) * Patient operated on at Strasbourg University Hospital between January 1, 2023, and December 31, 2023, for total knee, shoulder, or hip replacement. * Patients who underwent surgery at Strasbourg University Hospital between March 1, 2025, and July 31, 2025, involving surgery requiring intraoperative antibiotic prophylaxis. Exclusion Criteria: * Patients with a surgical indication without the use of implants. * Patients with a surgical indication without antibiotic prophylaxis.
Where it's running
-
Service de Pharmacie - Stérilisation - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Aurélie REITER-SCHATZ, MD
- Email: aurelie.reiter-schatz@chru-strasbourg.fr
- Phone: 33 3 68 76 50 14
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimizing allergy testing for cephalosporin antibiotics
This study is testing a new way to diagnose cephalosporin allergies in patients to help them avoid severe allergic reactions.
-
Patient-specific biomechanical modeling of incisional hernias with AI and finite element analysis
Researchers will test a personalized computer model of the abdominal wall for adults with incisional hernias using anonymized CT data and AI to see how the hernia shapes relate to tissue mechanics.
-
Menin inhibitors in pediatric relapsed or refractory acute leukemia
This study looks at kids with relapsed or treatment-resistant acute leukemia who have specific genetic changes and are treated with menin inhibitors to see how they fare.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Predictors of Success and Failure of v-NOTES Hysterectomy for Large Uteri
This study looks at which factors predict whether a v-NOTES hysterectomy for large uteri will be completed without needing to switch to another surgical approach.
-
Prehospital end-of-life care: how professionals use a comfort care booklet in Strasbourg
This study tests how emergency crew members in Strasbourg use a comfort care booklet when caring for patients at end of life, and what they think about it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.